AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
17,744,402
Share change
-505,623
Total reported value
$38,330,229
Price per share
$2.16
Number of holders
33
Value change
-$1,895,264
Number of buys
17
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q4 2018

As of 31 Dec 2018, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,744,402 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, Vanguard Group Inc, BlackRock Inc., D. E. Shaw & Co., Inc., OXFORD ASSET MANAGEMENT LLP, and Anson Funds Management LP. This page lists 33 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.